| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOMATERIALS.2011.02.048 |
| P8608 | Fatcat ID | release_gwitxxg4zbgddajy3wfbhpc2em |
| P932 | PMC publication ID | 5279724 |
| P698 | PubMed publication ID | 21429573 |
| P50 | author | Robert S. Langer, Jr. | Q669597 |
| Tram Dang | Q58036195 | ||
| P2093 | author name string | Daniel G Anderson | |
| Xiao Y Chen | |||
| Said R Bogatyrev | |||
| Kaitlin M Bratlie | |||
| P2860 | cites work | In vivo imaging of tumors with protease-activated near-infrared fluorescent probes | Q28141852 |
| Neutrophil granules and secretory vesicles in inflammation | Q28183749 | ||
| Proteomic analysis of human neutrophil granules | Q28258795 | ||
| Antiinflammatory action of glucocorticoids--new mechanisms for old drugs | Q28278037 | ||
| Rapid biocompatibility analysis of materials via in vivo fluorescence imaging of mouse models | Q28748163 | ||
| Multiphoton microscopy in life sciences | Q31833729 | ||
| Applications of laser scanning cytometry in immunohistochemistry and routine histopathology | Q33323516 | ||
| Implants for site-specific drug delivery | Q33577066 | ||
| Biodegradation and biocompatibility of PLA and PLGA microspheres | Q33933142 | ||
| The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices | Q34072262 | ||
| Characterization of implantable biosensor membrane biofouling | Q34166517 | ||
| Causes of limited survival of microencapsulated pancreatic islet grafts. | Q34341413 | ||
| Immune response in biocompatibility | Q35361398 | ||
| Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes | Q35945287 | ||
| Drug/device combinations for local drug therapies and infection prophylaxis | Q36335731 | ||
| Methods to assess in vitro drug release from injectable polymeric particulate systems | Q36363768 | ||
| Foreign body reaction to biomaterials | Q36575306 | ||
| On the mechanisms of biocompatibility | Q37148995 | ||
| Biomaterials/tissue interactions: possible solutions to overcome foreign body response | Q37689579 | ||
| Therapeutic applications of implantable drug delivery systems | Q38547753 | ||
| Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries | Q38561702 | ||
| Quantifying the soft tissue response to implanted materials. | Q40524750 | ||
| Assessment of chronically implanted subcutaneous glucose sensors in dogs: the effect of surrounding fluid masses | Q40786721 | ||
| Biocompatibility issues of implantable drug delivery systems | Q41296005 | ||
| Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels | Q42018952 | ||
| Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/pva hydrogel composites for implantable devices | Q42597893 | ||
| Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy | Q42857270 | ||
| Human macrophage-mediated biodegradation of polyurethanes: assessment of candidate enzyme activities | Q44089522 | ||
| Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control | Q45246743 | ||
| A dexamethasone-loaded PLGA microspheres/collagen scaffold composite for implantable glucose sensors. | Q45964208 | ||
| A comparative study of the action of dexamethasone sodium phosphate and dexamethasone acetate in steroid-eluting pacemaker leads | Q46434479 | ||
| Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres | Q47841062 | ||
| Silicone breast implants: the role of immune system on capsular contracture formation | Q49165438 | ||
| Biocompatibility of electrochemical glucose sensors implanted in the subcutis of pigs. | Q51139622 | ||
| Image analysis in the evaluation of biomaterials | Q56963942 | ||
| A hook-traction technique for Norplant removal | Q71761072 | ||
| Neutrophil-mediated degradation of segmented polyurethanes | Q72159805 | ||
| Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets | Q73186421 | ||
| Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties | Q73877182 | ||
| In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices | Q74082962 | ||
| In vivo imaging of proteolytic enzyme activity using a novel molecular reporter | Q74314878 | ||
| Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties | Q74583056 | ||
| Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times | Q74583061 | ||
| Anti-inflammatory drugs and their mechanism of action | Q77609041 | ||
| Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices | Q77844745 | ||
| Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets | Q77945094 | ||
| Lysosomal enzyme release from human neutrophils adherent to foreign material surfaces: enhanced release of elastase activity | Q87339622 | ||
| P433 | issue | 19 | |
| P921 | main subject | inflammation | Q101991 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 4464-4470 | |
| P577 | publication date | 2011-03-23 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Spatiotemporal effects of a controlled-release anti-inflammatory drug on the cellular dynamics of host response | |
| P478 | volume | 32 |
| Q26823654 | Biocompatible materials for continuous glucose monitoring devices |
| Q35609496 | Biomaterial-mediated modification of the local inflammatory environment. |
| Q38665547 | CD200 modulates macrophage cytokine secretion and phagocytosis in response to poly(lactic co-glycolic acid) microparticles and films |
| Q39322467 | Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response |
| Q36825938 | Dexamethasone Release from Within Engineered Cartilage as a Chondroprotective Strategy Against Interleukin-1α. |
| Q39398627 | Drug release patterns and cytotoxicity of PEG-poly(aspartate) block copolymer micelles in cancer cells |
| Q34713899 | Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug |
| Q87329732 | Implanted materials: Larger is stealthier |
| Q36302804 | Localized delivery of dexamethasone from electrospun fibers reduces the foreign body response. |
| Q34045963 | Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice |
| Q93001062 | Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations |
| Q38946134 | Methods for Implant Acceptance and Wound Healing: Material Selection and Implant Location Modulate Macrophage and Fibroblast Phenotypes |
| Q38165635 | Microdialysis sampling techniques applied to studies of the foreign body reaction |
| Q38668564 | Multicompartment Drug Release System for Dynamic Modulation of Tissue Responses |
| Q90397467 | Nanoparticle-based model of anti-inflammatory drug releasing LbL coatings for uncemented prosthesis aseptic loosening prevention |
| Q27314755 | Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates |
Search more.